Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

PDRN decreases the expression of cellular aging markers. by Jingjing Chen (293564)

<i>In vivo</i> treatment decreases bacterial burden and colonization of vital organs in a skin abscess biofilm infection model. by Robert L. Beckman I.V (22784303)

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

<i>shk-1</i> mutants display decreased glycogen storage. by Longjun Pu (20685717)

Changes in blood pressure, HbA1c, blood lipid and liver function-related indicator values compared with baseline values in all patients over time. by Jia Song (495396)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

K1 expression decreases in HA15 treated cells. by Guillermo Najarro (19964572)

A heat map to compare the associated resistances outlined in Table 1 and [14] with the IRP values. by J. Roadnight Sheehan (20141887)

Results of Analysis of Co-variance (ANCOVA) for change in parameter predicted by treatment group with pre-treatment value as a covariate. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

Subjects:

The values calculated for the inhibitor dissociation constant, as detailed in Eqs 10 and 11 and approximated values for the binding rate constants of the inhibitors. by J. Roadnight Sheehan (20141887)

Values for the calculation of the time-dependent drug concentrations in the system based on observed data found and derived from a variety of sources. by J. Roadnight Sheehan (20141887)

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

The values for <i>k</i>_cat and <i>K</i>_M are sourced from [19]. by J. Roadnight Sheehan (20141887)

Changes in blood pressure, HbA1c, blood lipids and liver function-related indicator values from 3 months to 6 months of treatment in all patients. by Jia Song (495396)

Top 20 IPA pathways of 2405 genes downregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Different calculated values for indication of resistance for each combination of mutant and inhibitor against IRP. by J. Roadnight Sheehan (20141887)

Mathematical treatments applied to data to correct stable isotope values for lipid content. by Nathan D. McTigue (10706460)

Subjects:

a-d. Difference in (a) probing depth; (b) clinical attachment level; (c) bleeding on probing, and (d) plaque index values between baseline and six months after treatment using syst... by Iva Milinkovic (22331710)

PRRSV enters MARC-145 cells via macropinocytosis and rottlerin blocks the macropinocytosis by decreasing actin polymerization. by Yeonglim Kang (21395261)